Yahoo Finance

Sagimet Biosciences Inc. (0O2.F)

Find the latest Sagimet Biosciences Inc. (0O2.F) stock quote, history, news and other vital information to help you with your stock trading and investing.
Yahoo Finance

Sagimet Biosciences Inc (0O2.MU)

Get the latest Sagimet Biosciences Inc (0O2.MU) stock news and headlines to help you in your trading and investment decisions.

Sagimet Biosciences Inc.: Sagimet Biosciences Receives FDA "Study May Proceed" Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients

Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...

Sagimet Biosciences Inc.: Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Phase 3 clinical trial of denifanstat in moderate to severe acne patients for the U.S. on track to initiate in second half of 2026 First-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 ongo ...
morningstar.com.au

Sagimet Biosciences Inc

Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways ...